Sarcoma (Jan 1997)

EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma

  • H. Jan Keizer,
  • Derek Crowther,
  • Ole Steen Nielsen,
  • Allan T. Van Oosterom,
  • Javier Hornedo Muguiro,
  • Christine Van Pottelberghe,
  • Renier Somers,
  • Thomas Tursz

DOI
https://doi.org/10.1080/13577149778371
Journal volume & issue
Vol. 1, no. 2
pp. 99 – 101

Abstract

Read online

Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS).